InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: stockweiser post# 174030

Wednesday, 04/23/2014 3:30:38 PM

Wednesday, April 23, 2014 3:30:38 PM

Post# of 345554
And that partner mentioned as Abbott was the first Big Pharma to split in two....followed by Pfizer. Some give the initial credit for the trend in Big Pharma that is seen developing to Pfizer....but maybe Abbott seen a paradigm shift coming much earlier than all other Big Pharmas. Wonder whats behind the magic of Bavi and PS Targeting that may cause Big Pharmas to split in two's.......and reorg.

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News